SB Agreement definition
Examples of SB Agreement in a sentence
Notwithstanding any provision of this Agreement, (a) the failure by Orchid to exercise any Option hereunder shall not in any way affect any exclusive licenses granted to Orchid herein or any licenses subsequently granted to Orchid by ▇▇▇▇▇▇▇, and (b) the scope of any licenses granted to Orchid in the SB Agreement shall not be limited or affected in any way by this Agreement.
The Joint Finance Subteam and the Joint Manufacture and Supply Chain Subteam established by SB and Corixa pursuant to the SB Agreement may periodically provide information to the JMC to help it coordinate the activities of the Parties and SB and optimize the implementation of this Agreement.
This Agreement, together with any agreements referenced herein, constitutes, on and as of the date hereof, the entire agreement of ▇▇▇▇▇▇▇ and Orchid with respect to the licensing or transfer of technology from ▇▇▇▇▇▇▇ to Orchid and all prior or contemporaneous understandings or agreements, whether written or oral, between ▇▇▇▇▇▇▇ and Orchid with respect to such subject matter are hereby superseded in their entirety except for the SB Agreement.
In the case of any conflict between the terms of this Agreement and the SB Agreement, the SB Agreement shall govern.
Except for licenses granted under the SB Agreement and except as described in Schedule A, ▇▇▇▇▇▇▇ has not granted any person or entity any right to use any of the patents or patent applications listed therein in the Orchid Field or the Option Fields.
All such obligations and liabilities (for certainty, including any and all existing and potential obligations under or relating to the ▇▇▇▇▇▇▇ Agreements and the SB Agreement, including royalty or milestone payments payable thereunder, [*]) are, and from and after the Closing shall be retained by and remain obligations and liabilities of, the Vendor.
In February 1999, the Company entered into an exclusive license agreement with SmithKline ▇▇▇▇▇▇▇ plc, London and SmithKline ▇▇▇▇▇▇▇, Philadelphia, wholly-owned subsidiaries of GlaxoSmithKline (collectively, SB) to develop and commercialize ImmunoGen's lead Tumor Activated Prodrug (or TAP), huC242-DM1 (the SB Agreement) for the treatment of colorectal, pancreatic and certain non-small lung cancers.
The BI Pharma Forecast may be part of the forecast for the same time period that SB provides to Corixa pursuant to the SB Agreement, provided that such forecast is received by Corixa by the date specified in the previous sentence and further provided that the Therapies that GSK Canada intends to purchase will be separately identified in such forecast.
The SB Agreement is expected to provide the Company with sufficient cash funding to carry out its responsibilities in developing huC242-DM1/SB-408075.
As of March 31, 2001, the Company had received five milestones totaling $11.5 million under the SB Agreement.